Deciphera Pharmaceuticals LLC Probability of Future Stock Price Finishing Over 14.65
| DCPHDelisted Stock | USD 13.32 0.36 2.63% |
Deciphera |
Deciphera Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Deciphera Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Deciphera Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Deciphera Pharmaceuticals is not yet fully synchronised with the market data | |
| Deciphera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 163.36 M. Net Loss for the year was (194.94 M) with loss before overhead, payroll, taxes, and interest of (62.55 M). | |
| Deciphera Pharmaceuticals LLC currently holds about 383.85 M in cash with (146.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
Deciphera Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Deciphera Stock often depends not only on the future outlook of the current and potential Deciphera Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Deciphera Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 85.1 M | |
| Cash And Short Term Investments | 306.2 M |
Deciphera Pharmaceuticals Technical Analysis
Deciphera Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Deciphera Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Deciphera Pharmaceuticals LLC. In general, you should focus on analyzing Deciphera Stock price patterns and their correlations with different microeconomic environments and drivers.
Deciphera Pharmaceuticals Predictive Forecast Models
Deciphera Pharmaceuticals' time-series forecasting models is one of many Deciphera Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Deciphera Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Deciphera Pharmaceuticals
Checking the ongoing alerts about Deciphera Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Deciphera Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Deciphera Pharmaceuticals is not yet fully synchronised with the market data | |
| Deciphera Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 163.36 M. Net Loss for the year was (194.94 M) with loss before overhead, payroll, taxes, and interest of (62.55 M). | |
| Deciphera Pharmaceuticals LLC currently holds about 383.85 M in cash with (146.7 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.74. | |
| Roughly 72.0% of the company shares are held by institutions such as insurance companies |
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.
Other Consideration for investing in Deciphera Stock
If you are still planning to invest in Deciphera Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Deciphera Pharmaceuticals' history and understand the potential risks before investing.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |